Top

 

References

  1. National Institute for Health and Clinical Excellence. Methylphenidate, atomoxetine and dexamfetamine for attention deficit hyperactivity disorder (ADHD) in children and adolescents. March 2013. www.nice.org.uk
  2. Diagnostic and Statistical Manual of mental disorders - Fifth Edition American Psychiatric Association, 2013.
  3. Scotish intercollegiate guidelines network (SIGN). Management of attention deficit and hyerpkinetic disorders in children and young people: A national clinical guideline. Guideline 112 October 2009.www.sign.ac.uk.
  4. Centers for disease control. Summary Health Statistics for US Children: National Interview Survey 2012 http://www.cdc.gov/nchs/data/series/sr_10/sr10_258.pdf Accessed January 2015.
  5. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review.J Am Acad Child Adolesc Psychiatry 1997;36: 1036-45.
  6. Nutt DJ, et al. Evidence-based guidelines for management of attention-deficit/ hyperactivity disorder in adolescents in transition to adult services and in adults: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2007;21(1): 10-41.
  7. Faraone SV, Perlis RH, Doyle AE, et al. Molecular genetics of attention-deficit/ hyperactivity disorder. Biol Psychiatry 2005; 57: 1313-1323.
  8. Castellanos FX, et al. Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/hyperactivity disorder. JAMA 2002; 288(14): 1740-8.
  9. Valera EM, et al. Meta-analysis of structural imaging findings in attention-deficit/ hyperactivity disorder. Biol Psychiatry 2007; 61(12): 1361-9.
  10. Spencer TJ, et al. Overview and neurobiology of ADHD. J Clinical Psych 2002; 63(S12): 3-9.
  11. Gillberg C, et al. Co-existing disorders in ADHD - implications for diagnosis and intervention. Eur Child Adolesc Psychiatry 2004; 13(Suppl 1):I80-92.
  12. Thompson AE, et al. Children with ADHD transferring to secondary school: Potential difficulties and solutions.Clinical Child Psychology and Psychiatry 2003;8(1): 91-103.
  13. All Party Parliamentary Group for Children (APPGC). `Every Child Matters` Green Paper. September 2003.
  14. Concerta XL Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/8382 Accessed January 2015.
  15. Equasym XL. Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/15804 Accessed January 2015.
  16. Ritalin. Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/1316 Accessed January 2015
  17. Dexamfetamine. Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/29014 Accessed January 2015
  18. Strattera. Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/14482 accessed January 2015.
  19. Elvanse (lisdexamfetamine). Summary of Product Characteristics. http://www.medicines.org.uk/emc/medicine/27442 accessed January 2015.
 

Top

ADHD-Mobile
Resource

Resources

Visit our resource centre for useful information and helpful activities for parents, teachers and teenagers living with ADHD.

 

Top

home_paralax_logo_320